Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
Samra Turajlic(Royal Marsden NHS Foundation Trust), Nicos Fotiadis(Royal Marsden NHS Foundation Trust), Ben Challacombe(Guy's and St Thomas' NHS Foundation Trust), Mickael Escudero(The Francis Crick Institute), Lavinia Spain(Royal Marsden NHS Foundation Trust), Sarkhara Sharma(The Francis Crick Institute), Kevin Litchfield(Cancer Research UK), Faiz Jabbar(The Francis Crick Institute), Sophia Ward(The Francis Crick Institute), Aengus Stewart(University of the Basque Country), Marta Costa(University of Minho), Ismaeel Aurangzeb(The Francis Crick Institute), Mary Varia(Guy's and St Thomas' NHS Foundation Trust), Greg Elgar(Genomics England), Sebastijan Hobor(The Francis Crick Institute), Emma Nye(The Francis Crick Institute), Gordon Stamp(Royal Marsden Hospital), Catherine Horsfield(St Thomas' Hospital), José I. López(BioCruces Health research Institute), Thomas B.K. Watkins(The Francis Crick Institute), Adam Huffman(The Francis Crick Institute), Eva Grönroos(The Francis Crick Institute), Joanna Lynch(Royal Marsden NHS Foundation Trust), Andrew Rowan(Cancer Institute (WIA)), Alexander Polson(Guy's and St Thomas' NHS Foundation Trust), Ben Phillimore(The Francis Crick Institute), Ashish Chandra(Guy's Hospital), Lewis Au(Royal Marsden NHS Foundation Trust), Nik Matthews(The Francis Crick Institute), Carolina Navas(The Francis Crick Institute), Sharanpreet Lall(CRUK Lung Cancer Centre of Excellence), Max Salm(Cancer Research UK), Aspasia Soultati, Stefan Boeing(The Francis Crick Institute), Jonathan C. Smith(The Francis Crick Institute), Tim Chambers(University of Canterbury), Mark Stares(Edinburgh Cancer Research), Claudia Eichler-Jonsson(The Francis Crick Institute), Thomas J. Mitchell(University of Cambridge), Hang Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xing Wei(Wuhan National Laboratory for Optoelectronics), Sharmin Begum(The Francis Crick Institute), David Nicol(Royal Stoke University Hospital), Sarah Rudman(Guy's and St Thomas' NHS Foundation Trust), Archana Fernando(Guy's and St Thomas' NHS Foundation Trust), Simon Chowdhury(Sarah Cannon Research Institute), Rosalie Fisher(Auckland City Hospital), Stuart Horswell(The Francis Crick Institute), Tim O’Brien(St Thomas' Hospital), Steve Hazell(Royal Marsden NHS Foundation Trust)
Cited by 680
Related Papers
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
|Science|2016|3.1k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
|New England Journal of Medicine|2017|1.8k